ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Lupin Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Lupin Pharmaceuticals, INC. (Lupin Pharmaceuticals, INC. 401(k) Profit Sharing Plan · EIN 16-1674598 · PN 001): $71.65M net assets, 461 active participants, and $1.25 per $10,000 (1.25 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorLupin Pharmaceuticals, INC.
Filing IdentifierLupin Pharmaceuticals, INC. 401(k) Profit Sharing Plan · EIN 16-1674598 · PN 001
Plan Category & State401(k) Defined Contribution (FL)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$71.65M
Active Participants461
Direct Admin Fee Rate$1.25 per $10,000 (1.25 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderT. Rowe Price
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($320,183, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI